379
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data

, &
Pages 210-214 | Received 29 Sep 2014, Accepted 02 Feb 2015, Published online: 04 Mar 2015
 

Abstract

Context. Atomoxetine (ATX) is the treatment of choice for attention deficit hyperactivity disorders with co-morbid risk of drug abuse, although its abuse potential needs to be qualified. The purpose of this study is to analyse ATX misuse in relation to therapeutic use and compare our results with that of methylphenidate (MPH). Methods and materials. Data on enquiries were extracted from the Danish Poison Information Centre database (January 2006 to June 2012), while data on therapeutic use were provided by the Danish State Serum Institute (2007–2011). Results: The study included 28 ATX and 394 MPH enquiries. Frequency of ATX enquiries did not show a significant correlation to either sale or number of treated patients but for MPH, both correlations were significant (p = 0.001 and p = 0.0008, respectively). The enquiries/number of treated patients relationship differed significantly between ATX and MPH (p = 0.018), but not the enquiries/sale relationship. The proportion of exposures motivated by recreational drug use was significantly lower for ATX (19%) than that for MPH (40%) (p = 0.038). Discussion and conclusion. These results suggest that ATX is used by adults for non-medical purposes including recreational use, but to a lesser extent than MPH.

Declaration of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.